Canopy Growth Corp (CGC)
9.03
-0.45
(-4.75%)
USD |
NASDAQ |
May 08, 16:00
9.18
+0.15
(+1.66%)
After-Hours: 07:26
Canopy Growth Enterprise Value: 998.86M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 08, 2024 | 998.86M |
May 07, 2024 | 1.033B |
May 06, 2024 | 1.051B |
May 03, 2024 | 1.090B |
May 02, 2024 | 1.097B |
May 01, 2024 | 1.180B |
April 30, 2024 | 1.677B |
April 29, 2024 | 1.079B |
April 26, 2024 | 1.133B |
April 25, 2024 | 1.114B |
April 24, 2024 | 1.138B |
April 23, 2024 | 1.144B |
April 22, 2024 | 1.036B |
April 19, 2024 | 1.044B |
April 18, 2024 | 1.035B |
April 17, 2024 | 912.48M |
April 16, 2024 | 931.61M |
April 15, 2024 | 957.13M |
April 12, 2024 | 1.032B |
April 11, 2024 | 1.064B |
April 10, 2024 | 1.152B |
April 09, 2024 | 1.156B |
April 08, 2024 | 1.244B |
April 05, 2024 | 1.249B |
April 04, 2024 | 1.212B |
Date | Value |
---|---|
April 03, 2024 | 1.313B |
April 02, 2024 | 1.082B |
April 01, 2024 | 1.007B |
March 28, 2024 | 1.107B |
March 27, 2024 | 1.191B |
March 26, 2024 | 979.90M |
March 25, 2024 | 886.06M |
March 22, 2024 | 1.022B |
March 21, 2024 | 736.63M |
March 20, 2024 | 734.81M |
March 19, 2024 | 670.11M |
March 18, 2024 | 659.18M |
March 15, 2024 | 601.78M |
March 14, 2024 | 573.53M |
March 13, 2024 | 590.85M |
March 12, 2024 | 587.20M |
March 11, 2024 | 595.40M |
March 08, 2024 | 599.05M |
March 07, 2024 | 591.76M |
March 06, 2024 | 586.29M |
March 05, 2024 | 584.47M |
March 04, 2024 | 596.31M |
March 01, 2024 | 613.62M |
February 29, 2024 | 620.91M |
February 28, 2024 | 627.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
573.53M
Minimum
Mar 14 2024
19.17B
Maximum
Feb 10 2021
4.619B
Average
3.937B
Median
Nov 30 2021
Enterprise Value Benchmarks
Tilray Brands Inc | 1.733B |
Clever Leaves Holdings Inc | -0.9979M |
Flora Growth Corp | 13.82M |
Acasti Pharma Inc | 2.050M |
Aurinia Pharmaceuticals Inc | 386.06M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -159.25M |
Revenue (Quarterly) | 57.67M |
Total Expenses (Quarterly) | 75.97M |
EPS Diluted (Quarterly) | -1.925 |
Gross Profit Margin (Quarterly) | 35.95% |
Profit Margin (Quarterly) | -276.2% |
Earnings Yield | -167.3% |
Normalized Earnings Yield | -86.46 |